Skip to Main Content (Press Enter)

Logo HUMANITAS
  • ×
  • Home
  • Corsi
  • Insegnamenti
  • Persone
  • Pubblicazioni
  • Competenze

UNI-FIND
Logo HUMANITAS

|

UNI-FIND

hunimed.eu
  • ×
  • Home
  • Corsi
  • Insegnamenti
  • Persone
  • Pubblicazioni
  • Competenze
  1. Pubblicazioni

Cholangiocarcinoma stem-like subset shapes tumor-initiating niche by educating associated macrophages

Articolo
Data di Pubblicazione:
2017
Abstract:
Background & Aims: A therapeutically challenging subset of cells, termed cancer stem cells (CSCs) are responsible for cholangiocarcinoma (CCA) clinical severity. Presence of tumor-associated macrophages (TAMs) has prognostic significance in CCA and other malignancies. Thus, we hypothesized that CSCs may actively shape their tumor-supportive immune niche. Methods: CCA cells were cultured in 3D conditions to generate spheres. CCA sphere analysis of in vivo tumorigenic-engraftment in immune-deficient mice and molecular characterization was performed. The in vitro and in vivo effect of CCA spheres on macrophage precursors was tested after culturing healthy donor cluster of differentiation (CD)14+ with CCA-sphere conditioned medium. Results: CCA spheres engrafted in 100% of transplanted mice and revealed a significant 20.3-fold increase in tumor-initiating fraction (p =0.0011) and a sustained tumorigenic potential through diverse xenograft-generations. Moreover, CCA spheres were highly enriched for CSC, liver cancer and embryonic stem cell markers both at gene and protein levels. Next, fluorescence-activated cell sorting analysis showed that in the presence of CCA sphere conditioned medium, CD14+ macrophages expressed key markers (CD68, CD115, human leukocyte antigen-D related, CD206) indicating that CCA sphere conditioned medium was a strong macrophage-activator. Gene expression profile of CCA sphere activated macrophages revealed unique molecular TAM-like features confirmed by high invasion capacity. Also, freshly isolated macrophages from CCA resections recapitulated a similar molecular phenotype of in vitro-educated macrophages. Consistent with invasive features, the largest CD163+ set was found in the tumor front of human CCA specimens (n=23) and correlated with a high level of serum cancer antigen 19.9 (n=17). Among mediators released by CCA spheres, only interleukin (IL)13, IL34 and osteoactivin were detected and further confirmed in CCA patient sera (n=12). Surprisingly, a significant association of IL13, IL34 and osteoactivin with sphere stem-like genes was provided by a CCA database (n=104). In vitro combination of IL13, IL34, osteoactivin was responsible for macrophage-differentiation and invasion, as well as for in vivo tumor-promoting effect. Conclusion: CCA-CSCs molded a specific subset of stem-like associated macrophages thus providing a rationale for a synergistic therapeutic strategy for CCA-disease. Lay summary: Immune plasticity represents an important hallmark of tumor outcome. Since cancer stem cells are able to manipulate stromal cells to their needs, a better definition of the key dysregulated immune subtypes responsible for cooperating in supporting tumor initiation may facilitate the development of new therapeutic approaches. Considering that human cholangiocarcinoma represents a clinical emergency, it is essential to move to predictive models in order to understand the adaptive process of macrophage component (imprinting, polarization and maintenance) engaged by tumor stem-like compartment.
Tipologia CRIS:
1.1 Articolo in rivista
Keywords:
cancer stem cells; cholangiocarcinoma; tumor-associated macrophages; hepatology
Elenco autori:
Raggi, C.; Correnti, M.; Sica, A.; Andersen, J. B.; Cardinale, V.; Alvaro, D.; Chiorino, G.; Forti, E.; Glaser, S.; Alpini, G.; Destro, A.; Sozio, F.; Di Tommaso, L.; Roncalli, M.; Banales, J. M.; Coulouarn, C.; Bujanda, L.; Torzilli, G.; Invernizzi, P.
Autori di Ateneo:
Di Tommaso Luca
Torzilli Guido
Link alla scheda completa:
https://iris.hunimed.eu/handle/11699/3392
Link al Full Text:
https://iris.hunimed.eu//retrieve/handle/11699/3392/12102/RaggiDestro_JournHepatology_Cholangiocarcinoma_2016.pdf
Pubblicato in:
JOURNAL OF HEPATOLOGY
Journal
  • Utilizzo dei cookie

Realizzato con VIVO | Designed by Cineca | 26.9.3.0